S&P rates University of Vermont Medical Center’s bonds

S&P Global Ratings has assigned its “A-” long-term rating to $89 million series 2016 B green bonds issued on behalf of University of Vermont Medical Center in Burlington by the Vermont Educational & Health Building Financing Agency.

Advertisement

Proceeds from the bonds will be used to help cover the cost of a $175 million construction project underway at University of Vermont Medical Center, which is the flagship of Burlington-based University of Vermont Health Network.

Jennifer Soule, an analyst at S&P Global Ratings, said the “A-” rating reflects the credit rating agency’s view of the hospital’s solid enterprise and financial profiles.

The hospital’s outlook is stable.

More articles on healthcare finance:

Tennessee hospital closure delayed
7 hospital CFOs in the headlines
Service cuts, layoffs may not be enough to save Oklahoma hospital, says CFO

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.